Display options
Share it on

Int J Biomater. 2012;2012:820513. doi: 10.1155/2012/820513. Epub 2012 Dec 13.

Effects of composition of iron-cross-linked alginate hydrogels for cultivation of human dermal fibroblasts.

International journal of biomaterials

Ikuko Machida-Sano, Sakito Ogawa, Hiroyuki Ueda, Yoshitaka Kimura, Nao Satoh, Hideo Namiki

Affiliations

  1. Department of Biology, School of Education, Waseda University, 2-2 Wakamatsu-cho, Shinjuku-ku, Tokyo 162-8480, Japan.

PMID: 23304153 PMCID: PMC3532874 DOI: 10.1155/2012/820513

Abstract

We investigated the suitability of ferric-ion-cross-linked alginates (Fe-alginate) with various proportions of L-guluronic acid (G) and D-mannuronic acid (M) residues as a culture substrate for human dermal fibroblasts. High-G and high-M Fe-alginate gels showed comparable efficacy in promoting initial cell adhesion and similar protein adsorption capacities, but superior cell proliferation was observed on high-G than on high-M Fe-alginate as culture time progressed. During immersion in culture medium, high-G Fe-alginate showed little change in gel properties in terms of swelling and polymer content, but the properties of high-M Fe-alginate gel were altered due to loss of ion cross-linking. However, the degree of cell proliferation on high-M Fe-alginate gel was improved after it had been stabilized by immersion in culture medium until no further changes occurred. These results suggest that the mode of cross-linkage between ferric ions and alginate differs depending on alginate composition and that the major factor giving rise to differences in cell growth on the two types of Fe-alginate films is gel stability during culture, rather than swelling of the original gel, polymer content, or protein adsorption ability. Our findings may be useful for extending the application of Fe-alginate to diverse biomedical fields.

References

  1. Tissue Eng. 2005 Jan-Feb;11(1-2):1-18 - PubMed
  2. Biotechnol Bioeng. 2011 Jul;108(7):1683-92 - PubMed
  3. J Biomed Mater Res. 2002 May;60(2):217-23 - PubMed
  4. Biomed Mater. 2009 Apr;4(2):025008 - PubMed
  5. Biomaterials. 2001 Jun;22(11):1301-10 - PubMed
  6. Trends Biotechnol. 1990 Mar;8(3):71-8 - PubMed
  7. J Biomed Mater Res. 1999 Oct;47(1):46-53 - PubMed
  8. Tissue Eng Part C Methods. 2009 Dec;15(4):541-50 - PubMed
  9. Biomaterials. 1996 Jan;17(2):137-46 - PubMed
  10. Biomacromolecules. 2006 May;7(5):1471-80 - PubMed
  11. Eur J Pharm Sci. 2006 Oct 1;29(2):139-47 - PubMed
  12. Biophys J. 2000 Jul;79(1):144-52 - PubMed
  13. J Biomed Mater Res A. 2007 Dec 1;83(3):887-94 - PubMed
  14. Ann Biomed Eng. 2010 Jan;38(1):2-20 - PubMed
  15. J Phys Chem B. 2009 Oct 1;113(39):12916-22 - PubMed
  16. J Mater Sci Mater Med. 2002 Jan;13(1):75-80 - PubMed
  17. Biomaterials. 2003 Sep;24(20):3475-81 - PubMed
  18. Transplantation. 1996 Oct 15;62(7):888-93 - PubMed
  19. J Biomed Mater Res A. 2008 Mar 15;84(4):899-907 - PubMed
  20. J Biomed Mater Res A. 2004 Oct 1;71(1):154-61 - PubMed

Publication Types